Propaten Randomized Investigation on Cost-benefit and Efficacy
Stopped early · Not applicable
Conditions studied: End-stage Renal Disease
In brief
The purpose for this study is to evaluate the patency and outcomes of conventional and heparin anticoagulant bonded arteriovenous grafts in patients with end stage renal disease.
Key facts
- Study ID
- NCT01601873
- Run by
- The University of Texas Health Science Center, Houston
- People needed
- 103
- Starts
- 2012-11-09
- Expected to finish
- 2018-06-30
- Last updated by the study team
- 2019-02-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Aged ≥18 years of all ethnicities
- End-stage Renal Disease stage 4 (GFR 15-29 ml/min 1.73m2) or stage 5 (GFR <15ml/min 1.73m2) per National Kidney Foundation guidelines
- Currently undergoing hemodialysis with a failure of previous access
- Expected to undergo hemodialysis within 6 months of presentation
You may not qualify if…
- Unable/refuse to abide with follow-up
- Known hypercoagulability syndrome or a bleeding disorder
- On a previous anticoagulant treatment
- Intraoperative decision in favor of fistula instead of graft
- Pregnant or breast-feeding women
- A documented history of heparin induced thrombocytopenia or allergy
- Active infections
- Evidence or suspicion of central vein stenosis
Where it is running
- University of Arkansas for Medical Sciences (UAMS) & Central Arkansas Veterans Healthcare System (CAVHS) — Little Rock, Arkansas, United States
- John Ochsner Heart & Vascular Institute Ochsner Medical Center — New Orleans, Louisiana, United States
- University Hospitals Cleveland Medical Center — Cleveland, Ohio, United States
- Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center — Houston, Texas, United States
- Department of Cardiothoracic and Vascular Surgery; Memorial Hermann Hospital Southeast — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.